Global Patterns of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors

被引:0
作者
Amakye, Dominic [1 ]
Ssentongo, Paddy [2 ]
Patel, Swapnil [3 ]
Dalessio, Shannon [4 ]
Kochhar, Smriti [3 ]
Momin, Arsh [3 ]
Clarke, Kofi [4 ]
机构
[1] Piedmont Athens Reg Med Ctr, Dept Internal Med, Athens, GA USA
[2] Penn State Coll Med, Dept Med, Div Infect Dis, Hershey, PA USA
[3] Penn State Coll Med, Dept Med, Hershey, PA USA
[4] Penn State Coll Med, Dept Med, Div Gastroenterol & Hepatol, Hershey, PA USA
关键词
Clostridioides difficile infection; inflammatory bowel disease; risk factors; epidemiology; meta-analysis; HOSPITALIZED-PATIENTS; MANAGEMENT; IMPACT; DIAGNOSIS; COLONIZATION; MICROBIOME; GUIDELINES; BURDEN; UPDATE; ADULTS;
D O I
10.1093/crocol/otaf024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Clostridioides difficile infection (CDI) is a well-recognized complication of inflammatory bowel disease (IBD) that has been associated with poor clinical outcomes. The objective of this study is to characterize the global incidence, risk factors and outcomes of CDI in patients with IBD.Methods A search of MEDLINE/PubMed, Scopus, and Cochrane Database of Systematic Reviews was conducted for studies published between January 1960, and March 2024. Random-effect models were employed to estimate the incidence of CDI in the IBD population. Risk factors and outcomes were estimated using random effects meta-regression and subgroup analysis.Results Twenty-eight articles from 11 countries on 3 continents, comprising 796, 244 patients with IBD were included. The overall CDI rate was 8.84% (95% CI, 5.91%-13.03%). The rate of CDI was slightly higher in Asia at 11% (95% CI, 6.7%-18.44%) compared to the North America (USA and Canada) at 7.85% (95% CI, 3.80%-15.51%) and Europe, where the incidence, was 7.92% (95% CI, 3.87%-15.51%). A univariable random-effects meta-regression model demonstrated that male gender (odds ratio [OR], 1.18; 95% CI, 1.00-1.40) and older age (OR, 1.06; 95% CI, 0.99-1.15, per one-year increase in age) were factors associated with higher CDI incidence in the IBD population. CDI testing by PCR compared to enzyme immunoassay was associated with higher rates of CDI (OR, 4.70; 95% CI, 01.39-15.90). No association was observed between length of hospital stay and CDI.Conclusions One in 10 patients with IBD were positive for CDI. Increasing age and male population were associated with higher risk of CDI. A systematic review and meta-analysis were performed to determine global incidence, risk factors and outcomes of Clostridioides difficile infection (CDI) in IBD patients. Findings showed a higher incidence in Asia and North America, with gender and age as risk factors.
引用
收藏
页数:12
相关论文
共 70 条
[51]   Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease [J].
Roy, Abhik ;
Lichtiger, Simon .
INFLAMMATORY BOWEL DISEASES, 2016, 22 (03) :648-653
[52]   The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease [J].
Saffouri, George ;
Gupta, Arjun ;
Loftus, Edward V., Jr. ;
Baddour, Larry M. ;
Pardi, Darrell S. ;
Khanna, Sahil .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (11) :1240-1247
[53]   Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions [J].
Schwarzer, Guido ;
Chemaitelly, Hiam ;
Abu-Raddad, Laith J. ;
Ruecker, Gerta .
RESEARCH SYNTHESIS METHODS, 2019, 10 (03) :476-483
[54]  
Schwarzer Guido., 2015, Meta-analysis with R, P165
[55]   Clostridium difficile Infection in Patients With Ileal Pouches [J].
Seril, Darren N. ;
Shen, Bo .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (07) :941-947
[56]   Clostridium difficile isolated from faecal samples in patients with ulcerative colitis [J].
Shoaei, Parisa ;
Shojaei, Hasan ;
Jalali, Mohammad ;
Khorvash, Farzin ;
Hosseini, Sayed Mohsen ;
Ataei, Behrooz ;
Vakili, Bahareh ;
Ebrahimi, Fatemeh ;
Tavakoli, Hossein ;
Esfandiari, Zahra ;
Weese, J. Scott .
BMC INFECTIOUS DISEASES, 2019, 19 (1)
[57]   Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis [J].
Slimings, Claudia ;
Riley, Thomas V. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) :881-891
[58]   Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection [J].
Sokol, Harry ;
Jegou, Sarah ;
McQuitty, Claire ;
Straub, Marjolene ;
Leducq, Valentin ;
Landman, Cecilia ;
Kirchgesner, Julien ;
Le Gall, Guillaume ;
Bourrier, Anne ;
Nion-Larmurier, Isabelle ;
Cosnes, Jacques ;
Seksik, Philippe ;
Richard, Mathias L. ;
Beaugerie, Laurent .
GUT MICROBES, 2018, 9 (01) :55-60
[59]   Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study [J].
Sokol, Harry ;
Lalandee, Valerie ;
Landman, Cecilia ;
Bourrier, Anne ;
Nion-Larmurier, Isabelle ;
Rajca, Sylvie ;
Kirchgesner, Julien ;
Seksik, Philippe ;
Cosnes, Jacques ;
Barbut, Frederic ;
Beaugerie, Laurent .
DIGESTIVE AND LIVER DISEASE, 2017, 49 (06) :643-646
[60]   Role of hospitalization for inflammatory bowel disease in the post-biologic era [J].
Soriano, Celine R. ;
Powell, Charleston R. ;
Chiorean, Michael V. ;
Simianu, Vlad V. .
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (26) :7632-7642